ORPHENADRINE CITRATE
- Product NDC
- 70934-952
- 11-digit product format
- 709340952
- Labeler code
- 70934
- Product ID
- 70934-952_d8a0d699-1348-82f6-e053-2a95a90aeac8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ORPHENADRINE CITRATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA040284
- Marketing category
- ANDA
- Marketing start
- 2022-02-22
- Marketing end
- 0000-00-00
- Substance
- ORPHENADRINE CITRATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X0A40N8I4S | ORPHENADRINE CITRATE | 4682-36-4 | ORPHENADRINE CITRATE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-952-14 | 70934095214 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-952-14) | 2022-02-22 | 0000-00-00 | No | No | Current |